Line Plot from Scientific Research

Percent change from baseline for ApoC-III over time after either IV (dashed lines) or SC (solid lines) treatment with LY3475766 (placebo, n = 12; LY 10 mg, n = 6; LY 30 mg, n = 6; LY 100 mg, n = 6; LY 300 mg, n = 12; LY 600 mg, n = 6). Data are given as the least-squares mean (s.e.).

DOI